每当我尝试在Xcode 6 Beta 4中运行我的应用程序时,我都会得到错误:
The file "MyApp.app" couldn't be opened because you don't have permission to view it.
无论我的目标是什么模拟器或设备,都会出现此错误。
我试过:
在Xcode中删除所有来自组织者的派生数据 正在修复驱动器上的权限 手动提升构建的MyApp.app的权限 重启电脑
有没有其他人遇到过这个问题并找到了解决方案?
每当我尝试在Xcode 6 Beta 4中运行我的应用程序时,我都会得到错误:
The file "MyApp.app" couldn't be opened because you don't have permission to view it.
无论我的目标是什么模拟器或设备,都会出现此错误。
我试过:
在Xcode中删除所有来自组织者的派生数据 正在修复驱动器上的权限 手动提升构建的MyApp.app的权限 重启电脑
有没有其他人遇到过这个问题并找到了解决方案?
当前回答
None of the provided answers worked for me. In my case, I finally fixed the error by updating the target architectures in Build Settings/Architectures/Valid Architectures to $(ARCHS_STANDARD), as arm64 was missing. This was not prohibiting the project to build, although a warning was issued recommending updating the valid architectures, but the "app could not be opened" error was shown at run time. I surmise this error is rather generic and not always linked with a permission issue, but may be displayed when the generated app package is invalid.
其他回答
也许可以考虑安装最新版本的Xcode。
在尝试了所有其他的解决方案(对我来说并不管用)之后,我这样做了,这个问题自动得到了解决。
我有类似的问题(xCode 6.2)的示例代码下载。我试图在信息中将可执行名称设置为默认。但是这并没有起作用。
相反,将Compiler for C/ c++ /Objective-C更改为Default Compiler(Apple LLVM 6.0),而不是Unsupported Compiler(com.apple.compilers.llvmgcc42) for project。
这是因为您可能会使用从git或svn克隆的存储库。尝试克隆另一个新版本并运行它。
因为我今天早上也遇到了这个问题,没有一个答案对我有帮助,尤其是在我的情况下。经过几个小时的努力,我终于找到了问题所在。
实际上,在故事板中工作时,我错误地重命名了我的“Main”。故事板“到”。并将其更改为“Main”。故事板解决了我的问题。
解决方案(根据我的问题):可能是你重命名了任何文件,因为xcode无法加载它,并提出了一个问题。 例如:如上文所述更改“可执行文件”名称的情况 可能的问题区域:可能是您使用的最后几个文件。
What we didn't do right was to not apply with the accurate code when signing in the Build Settings. We fixed the issue up this way: Enter into Build Settings >> Code Signing >> Code Sign Identity. Then, apply with your iOS Developer ID for 'Debug', but be sure to apply with your iOS Distribution Profile for 'Release' We didn't apply correctly, so we couldn't have permission to ask for the App from the server, actually. Anyway this post forced us to revise all the parameters and requirements, so we pretty appreciate all your answers. Regards, T.